Share
Cancer Research & Oncology 2021
Labroots Virtual Event
October 06, 2021, at 6:00 AM PST - October 07, 2021, at 5:00 PM PST
The Labroots Cancer Research and Oncology Virtual Event provides a robust platform for cancer researchers to collaborate on recent developments in the prevention, diagnosis, and treatment of cancer. At this virtual event, we showcased our latest 2-D and 3-D patient-derived cancer models, EMT and THP-1 reporter cell lines, human primary cells, cancer panels, and more! Check out our resources for cancer research below to see how we can support your next project.
Did you miss us at the event and want to speak to one of ATCC’s representatives about a product or service? Contact us so we can discuss your needs.
Human Cancer Models Initiative
ATCC is collaborating with the Human Cancer Models Initiative (HCMI) to offer scientists a wide variety of next-generation 2D and 3D patient-derived in vitro cancer models, including organoids. ATCC is committed to making available a growing collection of models generated by the HCMI, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These HCMI models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.
Find next-generation modelsResources for cancer research
THP-1 reporter cells
ATCC offers luciferase reporters containing the response element of immunologically important transcription factors into the THP-1 cell line. These advanced models provide a robust and highly sensitive means to measure immune activation through in vitro bioluminescence.
Order THP-1 reporter cell lines
EMT reporter cells
Epithelial-mesenchymal transition (EMT) and its reverse, MET, can play critical roles in promoting metastasis and invasion and contribute to drug resistance in carcinoma. ATCC used CRISPR gene editing to develop new reporter lines designed to enable the real-time monitoring of the changing status of cells from epithelial to mesenchymal.
Enhance your research
Next-generation cancer models
ATCC is offering scientists a wide variety of next-generation patient-derived in vitro cancer models, including organoids, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These advanced models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.
Discover how
Luciferase-labeled cell lines
ATCC is bridging the gap between the in vitro and the in vivo by offering luciferase-labeled cell lines for biological mechanism studies and drug development; these advanced models provide a relatively simple, robust, and highly sensitive means to measure biological processes and to assess drug efficacy in live animal models through bioluminescence imaging.
Get started
Cancer panels
ATCC offers a wide variety of cancer cell lines for use in research related to cancer genetics, early detection methods, and effective treatment of disease. Panels of these cell lines offer researchers the value of several lines for comprehensive studies. Explore our panels by tissue type, genetic mutation, or molecular signature.
Order cancer panels
Isogenic cells
Clinically relevant cell models are critical for studies of molecular and cellular mechanisms of tumors, as well as for drug screening for cancer. With genome editing tools such as CRISPR/Cas9, ATCC has created isogenic cell lines with mutants of key oncogenes, which are ideal for elucidating molecular pathways of cancer progression.
Explore isogenic cellsContact us today!
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
